CytomX Therapeutics, Inc.
CTMX
$2.98
$0.041.36%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 152.97% | -4.58% | -9.15% | 97.89% | -20.61% |
| Total Receivables | -67.91% | 23.57% | -12.84% | -4.45% | -36.96% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 18.27% | 22.56% | -15.07% | -2.53% | 33.72% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 145.34% | -3.55% | -9.36% | 90.03% | -19.27% |
|
|
|||||
| Total Current Assets | 145.34% | -3.55% | -9.36% | 90.03% | -19.27% |
| Net Property, Plant & Equipment | -28.64% | -28.08% | -17.21% | -14.98% | -12.44% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -8.45% | -7.59% | -7.06% | -6.76% | -6.17% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 44.39% | -0.46% | -0.46% | -0.37% |
| Total Assets | 137.10% | -4.23% | -9.60% | 77.73% | -18.28% |
|
|
|||||
| Total Accounts Payable | 5.15% | 101.39% | 184.58% | -17.75% | -74.63% |
| Total Accrued Expenses | -15.88% | 15.03% | 8.65% | 7.49% | -14.48% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -32.64% | -24.23% | 2.81% | 2.83% | 2.88% |
| Total Finance Division Other Current Liabilities | -33.55% | 19.74% | 1.14% | -34.83% | -49.28% |
| Total Other Current Liabilities | -33.55% | 19.74% | 1.14% | -34.83% | -49.28% |
| Total Current Liabilities | -27.01% | 13.61% | 4.60% | -21.87% | -41.47% |
|
|
|||||
| Total Current Liabilities | -27.01% | 13.61% | 4.60% | -21.87% | -41.47% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -49.51% | -32.64% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -9.29% | -39.58% | -32.08% | -28.98% | -34.17% |
| Total Liabilities | -25.01% | 3.33% | -7.76% | -24.92% | -39.29% |
|
|
|||||
| Common Stock & APIC | 29.50% | 2.67% | 0.21% | 13.70% | 0.29% |
| Retained Earnings | -2.56% | -4.32% | -2.13% | -0.02% | 3.40% |
| Treasury Stock & Other | -8.11% | 6.73% | 215.15% | 3,400.00% | -103.70% |
| Total Common Equity | 223.15% | -7.80% | -10.44% | 378.70% | 5,593.20% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 223.15% | -7.80% | -10.44% | 378.70% | 5,593.20% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 223.15% | -7.80% | -10.44% | 378.70% | 5,593.20% |
|
|
|||||